Echo Street Capital Management’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,306
Closed -$510K 597
2021
Q1
$510K Buy
+1,306
New +$643K ﹤0.01% 285

Other funds holding BLUE

Echo Street Capital Management's BLUE Position: Q2 2021 in Review

Echo Street Capital Management sold out of bluebird bio (BLUE) in Q2 2021, closing a stake of 1,306 shares — an estimated $510K sold.

Echo Street Capital Management first reported a position in BLUE in Q1 2021 and held it in 1 quarter. The position peaked at $510K in Q1 2021. 232 funds tracked by Wall St. Rank hold BLUE as of Q2 2021.

  • Echo Street Capital Management reported no remaining bluebird bio position as of Q2 2021 after selling out during the quarter.
  • Echo Street Capital Management sold 1,306 bluebird bio shares in Q2 2021, an estimated $510K.
  • Echo Street Capital Management first reported a position in bluebird bio in Q1 2021 and held it in 1 quarter.
  • Echo Street Capital Management's bluebird bio position peaked at $510K in Q1 2021.
  • 232 funds tracked by Wall St. Rank held bluebird bio as of Q2 2021.

Based on Echo Street Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.